Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals
Bibliographic Data
| ID | 4424990 |
|---|---|
| Authors | Mary E Smith (0000-0002-6203-317X), Martha J Farah (0000-0002-6683-0352) |
| Year | 2011 |
| Volume | 137 |
| Issue | 5 |
| Pages | 717-741 |
| Publication date | 2011-09-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Psychological Bulletin (JOURNAL) |
| Journal identifiers | ISSN: 0033-2909 • E-ISSN: 1939-1455 |
| Publisher | American Psychological Association (APA) (PUBLISHER) |
| DOI | 10.1037/a0023825 |
| PMID | 21859174 |
| PMCID | PMC3591814 |
| OpenAlex | W2099564435 |
| Language | EN |
| Citations received | 45 |
Use of prescription stimulants by normal healthy individuals to enhance cognition is said to be on the rise. Who is using these medications for cognitive enhancement, and how prevalent is this practice? Do prescription stimulants in fact enhance cognition for normal healthy people? We review the epidemiological and cognitive neuroscience literatures in search of answers to these questions. Epidemiological issues addressed include the prevalence of nonmedical stimulant use, user demographics, methods by which users obtain prescription stimulants, and motivations for use. Cognitive neuroscience issues addressed include the effects of prescription stimulants on learning and executive function, as well as the task and individual variables associated with these effects. Little is known about the prevalence of prescription stimulant use for cognitive enhancement outside of student populations. Among college students, estimates of use vary widely but, taken together, suggest that the practice is commonplace. The cognitive effects of stimulants on normal healthy people cannot yet be characterized definitively, despite the volume of research that has been carried out on these issues. Published evidence suggests that declarative memory can be improved by stimulants, with some evidence consistent with enhanced consolidation of memories. Effects on the executive functions of working memory and cognitive control are less reliable but have been found for at least some individuals on some tasks. In closing, we enumerate the many outstanding questions that remain to be addressed by future research and also identify obstacles facing this research
Cognition · Executive functions · Medical prescription · Psychiatry · Stimulant · Working memory · Attention Deficit Hyperactivity Disorder · Functional Brain Connectivity Studies · Medicine · Neuroethics, Human Enhancement, Biomedical Innovations · Psychology · Clinical Psychology · Cognitive Neuroscience · Pharmacology
Insiders, smart drugs et pharmaceuticalisation
Pharmacological cognitive enhancers
Contrast of medical and nonmedical use of stimulant drugs, basis for the distinction, and risk of addiction
Neural and Cognitive Plasticity
The use of Image and Performance-Enhancing Drugs (Iped) in behavioural addictions
The relevance of pharmacological neuroenhancement for stress and resilience—A multistudy report
Acceptability of Neuroscientific Interventions in Education
Cognitive Enhancement
Cognitive Enhancing Drugs in Sport
Towards an understanding of how stress and resources affect the nonmedical use of prescription drugs for performance enhancement among employees
Exploring Irish students’ attitudes towards nootropic supplements
Study drug use among university students in Western Australia
‘I’d struggle to see it as cheating’
How has neuroscience affected lay understandings of personhood? A review of the evidence
Modeling students’ instrumental (mis-) use of substances to enhance cognitive performance
Implicações do uso descontrolado de nootrópicos tarja preta na potencialização do desempenho acadêmico
The Dark Triad of personality and attitudes toward cognitive enhancement
Is the use of modafinil, a pharmacological cognitive enhancer, cheating
Neuroenhancement as Instrumental Drug Use
Neuroenhancement in French and Romanian University Students, Motivations and Associated Factors
Use of Neuroenhancement Drugs
Investigating the landscape of cognitive enhancers use among future physicians
Non-medical prescription stimulant use
Circadian leadership
Subtypes of prescription stimulant misuse among students
Neuropsychological Effects of Placebo Stimulants in College Students
The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving
Learning Approaches and Attitudes Toward Cognitive Enhancers in UK University Students
Use, Perceptions and Attitudes of Cognitive and Sports Performance Enhancing Substances Among University Students
Are Better Workers Also Better Humans? On Pharmacological Cognitive Enhancement in the Workplace and Conflicting Societal Domains
Visions and Ethics in Current Discourse on Human Enhancement
From the necessity of being human to the possibility of pursuing a good life
Academic Doping
The White Version of Cheating?” Ethical and Social Equity Concerns of Cognitive Enhancing Drug Users in Higher Education
Cognitive enhancement in the judiciary
Beyond Treatment Versus Enhancement
Toward the Smarter Use of Smart Drugs
Neither Licit nor Illicit
Neuroethics
How the Public Engages With Brain Optimization
Parental intervention in school, academic pressure, and childhood diagnoses of ADHD
Medical Adaptation to Academic Pressure
At Such a Good School, Everybody Needs It
Relationships between an ADHD Diagnosis and Future School Behaviors among Children with Mild Behavioral Problems
Prevalence of Legal, Prescription, and Illegal Drugs Aiming at Cognitive Enhancement across Sociodemographic Groups in Germany
| Unique citing works | 45 |
|---|---|
| Citations per year | 3 |
| Citation span | 2011 - 2026 (16) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 42 |